tiprankstipranks
Viemed Healthcare Inc (DE:VIJ)
FRANKFURT:VIJ

Viemed Healthcare (VIJ) Price & Analysis

1 Followers

VIJ Stock Chart & Stats

€9.95
€0.10(1.02%)
At close: 4:00 PM EDT
€9.95
€0.10(1.02%)

Bulls Say, Bears Say

Bulls Say
High Gross And EBITDA MarginsSustained high gross margins and mid-teens to low‑20s EBITDA margins reflect durable unit economics from recurring rentals, resupply and clinical services. That structural margin profile supports reinvestment in clinical scale, resilience to reimbursement shifts, and consistent operating cash flow generation.
Conservative Balance SheetExtremely low leverage and meaningful available credit provide financial flexibility to fund organic growth, acquisitions and capital expenditures while buffering reimbursement cycles. This conservative financing reduces refinancing risk and supports strategic funding choices like targeted buybacks or integration investment.
Diversifying Revenue Mix & ScaleRapid growth in sleep (PAP) and doubled equipment/supply sales, plus maternal health expansion, reduce concentration on ventilator rentals. A broader recurring-resupply base and new patient channels improve revenue predictability, capital efficiency and lowers single-segment exposure over the medium term.
Bears Say
Volatile Free Cash Flow ConversionFree cash flow has swung materially due to working-capital timing and investment cadence, making cash conversion less predictable. Inconsistent FCF limits the company's ability to reliably fund M&A, buybacks or increased capex without leaning on credit, especially if working-capital pressures reappear.
NCD-driven Ventilator Access RiskPolicy and compliance (NCD) changes raise structural risk to ventilator census and rental revenue via faster turnover or temporary patient ineligibility. That regulatory dependence increases clinical and administrative burden and can permanently reduce rental revenue if access rules tighten or compliance episodes persist.
Elevated SG&A And Thin Net MarginsRising absolute SG&A from staffing and acquisition integration pressures bottom-line conversion; despite strong gross margins, net margin remains muted (~5–6% TTM). Persistent SG&A growth could constrain leverage of revenue gains into net income and long-term free cash flow expansion.

Viemed Healthcare News

VIJ FAQ

What was Viemed Healthcare Inc’s price range in the past 12 months?
Viemed Healthcare Inc lowest stock price was €4.82 and its highest was €10.50 in the past 12 months.
    What is Viemed Healthcare Inc’s market cap?
    Viemed Healthcare Inc’s market cap is €387.80M.
      When is Viemed Healthcare Inc’s upcoming earnings report date?
      Viemed Healthcare Inc’s upcoming earnings report date is Aug 03, 2026 which is tomorrow.
        How were Viemed Healthcare Inc’s earnings last quarter?
        Viemed Healthcare Inc released its earnings results on May 05, 2026. The company reported €0.052 earnings per share for the quarter, missing the consensus estimate of €0.078 by -€0.026.
          Is Viemed Healthcare Inc overvalued?
          According to Wall Street analysts Viemed Healthcare Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Viemed Healthcare Inc pay dividends?
            Viemed Healthcare Inc does not currently pay dividends.
            What is Viemed Healthcare Inc’s EPS estimate?
            Viemed Healthcare Inc’s EPS estimate is 0.1.
              How many shares outstanding does Viemed Healthcare Inc have?
              Viemed Healthcare Inc has 38,336,803 shares outstanding.
                What happened to Viemed Healthcare Inc’s price movement after its last earnings report?
                Viemed Healthcare Inc reported an EPS of €0.052 in its last earnings report, missing expectations of €0.078. Following the earnings report the stock price went down -7.051%.
                  Which hedge fund is a major shareholder of Viemed Healthcare Inc?
                  Currently, no hedge funds are holding shares in DE:VIJ
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Viemed Healthcare Inc

                    Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

                    Viemed Healthcare (VIJ) Earnings & Revenues

                    VIJ Company Deck

                    VIJ Earnings Call

                    Q1 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call presented strong operational and financial progress: revenue growth of 28% YoY, substantial free cash flow improvement, meaningful scaling in sleep (PAP up 57% YoY) and maternal health expansion, improved capital efficiency and a stronger, more diversified revenue mix. Near-term headwinds are largely related to NCD-driven compliance effects in ventilation (higher turnover and temporary pressure on net census), some seasonality, and comparability issues from a prior-year gain. Management reiterated positive guidance, tightened revenue guidance upward, and highlighted continued margin and cash-flow improvement, indicating confidence in execution.View all DE:VIJ earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Inogen
                    Senseonics Holdings
                    Tactile Systems Technology
                    Outset Medical
                    Bioventus
                    Popular Stocks